Whether you need assistance with one part of your clinical trial or a full service UK CRO, PHARMExcel supports sponsors to design and deliver robust, patient centred respiratory clinical trials. We work with biotechs, medtech companies, charities and NHS or academic sponsors, providing agile, hands on support from early feasibility through to close out and reporting.
Respiratory clinical trials explained
Respiratory clinical trials are essential for improving care in conditions such as asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, pulmonary fibrosis, bronchiectasis and other acute or chronic respiratory disorders. These studies often involve complex endpoints, repeated functional assessments and patient populations whose symptoms can fluctuate significantly over time. Trial design must therefore balance scientific rigour with practical, acceptable procedures for patients and sites.
Why respiratory trials need specialist expertise
Respiratory studies can be challenging to design and deliver because disease severity, symptom burden and background treatment can vary widely between patients. Endpoints may include lung function testing, symptom scores, exacerbation rates, imaging, exercise tolerance or quality of life measures, all of which require careful planning and consistent collection. In some studies, seasonal variation, infection risk or environmental triggers can also affect recruitment windows, symptom patterns and data interpretation.
Many respiratory patients are living with chronic breathlessness, fatigue and multiple comorbidities, which can make trial participation more demanding. Visit schedules, testing requirements and protocol procedures need to be realistic for both patients and sites, particularly in busy respiratory clinics and specialist hospital services. Studies involving rare respiratory indications or vulnerable patient populations may add further complexity, requiring access to the right centres and clear governance around recruitment pathways.
Working with a CRO that understands these practical and clinical nuances helps to reduce avoidable amendments, improve protocol feasibility and maintain data quality throughout the study.
Our approach as your respiratory CRO partner
Sponsors choose PHARMExcel when they need a partner that can operate as an extension of their own team rather than a distant service provider. As a smaller organisation, we offer direct access to experienced senior staff and continuity of the same core project team throughout the life of your respiratory trial. This allows for faster responses, informed discussions around risk and mitigation, and a collaborative approach when challenges arise.
Our work is underpinned by a formal quality management system and adherence to GCP, but we apply these standards in a way that remains flexible and proportionate to the needs of each study. We take time at the outset to understand your programme, internal ways of working and expectations for communication and reporting. For overseas sponsors, our knowledge of NHS and academic research environments helps to bridge the gap between global plans and UK site realities.
Commercially, our aim is to give you clarity and control. We provide transparent, itemised budgets and can shape our involvement around your internal capabilities, from full service respiratory CRO support to focused assistance with defined aspects of your programme.
Governance and oversight across specialist respiratory networks
Respiratory studies often depend on access to the right specialist centres, experienced investigators and site teams that understand the demands of pulmonary research. PHARMExcel brings governance and oversight to this process by helping sponsors identify the most appropriate respiratory clinics, hospital departments and centres of excellence for their protocol, based on patient population, site capability and study complexity.
Where studies require specialist procedures, imaging or functional respiratory assessments, we work with sponsors and sites to ensure those services are embedded through the right network of centres and partners. Our role is not to perform these procedures directly, but to provide the governance, oversight and coordination needed to ensure they are delivered consistently and in line with protocol requirements.
For studies involving harder to reach or clinically vulnerable populations, this network-led approach is particularly valuable. It allows sponsors to plan realistic recruitment pathways and site strategies while maintaining close oversight of timelines, patient burden and operational risk.
Planning respiratory studies that work in practice
For each new study, we work with sponsors and investigators to test core assumptions, sense check eligibility criteria and ensure visit schedules and assessments can be delivered reliably at the proposed sites. Because we understand the pressures on respiratory services, we focus on pragmatic solutions that support site engagement, feasible recruitment pathways and high quality data rather than idealised but impractical designs.
This is especially important in respiratory trials where functional assessments, symptom reporting and exacerbation monitoring can create a significant burden for patients and study teams. A well planned protocol does more than satisfy scientific objectives – it also needs to fit real clinic pathways, site capacity and the lived experience of the patient population.
As a specialist UK CRO, we are particularly well placed to support sponsors who are new to the UK research environment. We provide clear, candid feedback on feasibility, realistic timelines and the types of centres most suited to your protocol, helping you to plan a trial that works on paper and in practice.
Discuss your next respiratory study with us
Whether you are planning an early phase respiratory trial in the UK or expanding an existing programme into new sites, PHARMExcel can help you assess feasibility, refine your protocol and plan delivery. To explore how our respiratory CRO services could support your next study, contact our team to arrange an initial discussion.
Respiratory CRO FAQs
What does a respiratory CRO do for sponsors?
A respiratory CRO provides specialist clinical trial governance and oversight for studies in pulmonary and respiratory conditions. For sponsors, this can include feasibility assessments, protocol review, regulatory and ethics submissions, project management, monitoring, safety oversight, data management and operational coordination across specialist sites. A CRO with respiratory experience understands the procedures, endpoints and patient considerations involved and can help translate that into a realistic, deliverable study plan.
Which respiratory conditions can PHARMExcel support?
PHARMExcel can support respiratory clinical trials across a broad range of acute and chronic indications, including asthma, COPD, pulmonary fibrosis, interstitial lung disease, bronchiectasis and other respiratory disorders where specialist site oversight and careful protocol delivery are required. We work with sponsors to understand the target population, current standard of care and study objectives, then align the trial with the most appropriate specialist centres and pathways.
How does PHARMExcel approach recruitment in respiratory trials?
PHARMExcel does not directly recruit patients. Instead, we provide governance and oversight of site-level recruitment by helping sponsors identify the right sites, assess realistic recruitment pathways and work closely with investigators and research teams who know the local patient population. This approach is particularly important in respiratory studies, where disease severity, comorbidities and burden of participation can all influence enrolment and retention.
Can PHARMExcel oversee studies involving specialist respiratory assessments?
Yes. Many respiratory trials depend on specialised procedures and assessments such as lung function testing, imaging, symptom scoring or exercise-based outcomes. PHARMExcel does not perform these assessments directly, but we provide governance and oversight by helping sponsors connect with sites and centres that have the right expertise, processes and infrastructure in place to deliver them consistently.
How does PHARMExcel ensure quality and regulatory compliance in respiratory trials?
Our work is guided by a formal quality management system and adherence to GCP. For each respiratory study, we apply processes that are proportionate to the risk profile of the trial while maintaining clear oversight of site activity, protocol compliance, safety reporting and data quality. We also support sponsors with regulatory and ethics submissions and help ensure the study is delivered in line with UK regulatory expectations.
How does working with a smaller UK CRO benefit respiratory studies?
Working with a smaller CRO gives sponsors direct access to experienced senior staff, continuity of the same core team and shorter communication lines throughout the study. In respiratory trials, where protocols can be complex and site realities vary, this helps sponsors make faster, better informed decisions. Our familiarity with NHS and academic environments also helps align respiratory studies with real world site capacity and patient pathways.